Cancer Research · 2005 · 159 citations · 15 references
Life SciencesCell BiologyOncologyApoptosisCell SignalingSignal TransductionApoptosis In CancerApoptosis RegulationApoptotic Signal TransductionApoptotic SignalingDeath ReceptorsExtrinsic Apoptotic PathwayApoptosis Signaling In CancerApoptotic Signaling CascadesChronic Lymphocytic Leukemia TherapyDeath Ligand SignalingDeath-inducing Signaling Complex AssemblyTrail ReceptorsTrail-mediated ApoptosisTumor Necrosis Factor-related Apoptosis-inducing Ligand Receptors
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its agonistic antibodies, which are currently in early clinical trials for treating various malignancies, induce apoptosis through triggering of either TRAIL-R1 or TRAIL-R2. Based on studies using agonistic monoclonal antibodies, we recently proposed that primary chronic lymphocytic leukemic cells seem to signal apoptosis primarily through TRAIL-R1. We have now synthesized mutant forms of TRAIL specific for TRAIL-R1 or TRAIL-R2. The selectivity of these mutants to induce apoptosis in cell lines is due to selective binding to their cognate receptors resulting in apoptosis via formation of a death-inducing signaling complex. Using these mutants, we now unequivocally show that primary cells from patients with chronic lymphocytic leukemia and mantle cell lymphoma signal to apoptosis almost exclusively through TRAIL-R1. Thus, no significant therapeutic benefit can be anticipated from treating such patients with agents currently in clinical trials that signal predominantly through TRAIL-R2, such as HGS-ETR2 or Apo2L/TRAIL. Our study highlights the necessity to determine whether primary cells from a particular tumor signal via TRAIL-R1 or TRAIL-R2. Such information will provide a rational approach to optimize TRAIL therapy.
15
ESPript: analysis of multiple sequence alignments in PostScript.
Patrice Gouet, Emmanuel Courcelle, David I. Stuart et al. · Bioinformatics · 1999 · 2.9K citations · Full text
TRAIL receptor-2 signals apoptosis through FADD and caspase-8
Jean-Luc Bodmer, Nils Holler, Séverine Reynard et al. · Nature Cell Biology · 2000 · 646 citations